More results...

More results...

ESMO 2024

We are excited to invite you to join us at ESMO 2024! Find out how we advance data-driven medicine, with our cloud-based SOPHiA DDM™ Platform. Discover how it empowers health data interpretation with advanced analytics modules, simplified reporting, and a global community of healthcare institutions.​

By harnessing the power of AI and multimodal data-driven analytics, we enable you to advance and streamline global access to precision therapies. ​

Posters: September 13th, 08:30 to 10:00 AM​

Analytical Validation of an NGS Panel-Based ecDNA Detection Device for Use as a Clinical Trial Assay for BBI-335 Clinical Study​

Presented by

Julien Pontis​
Technical Product Manager and Lead Data Scientist at SOPHiA GENETICS​

TRIDENT: Machine learning (ML) multimodal signatures to identify patients that would benefit most from tremelimumab (T) addition to durvalumab (D) + chemotherapy (CT) with data from the POSEIDON trial​

Presenter TBD

Event Date
September 13, 2024 – September 16, 2024

Event Type

In-person

Event Location

Europe

Areas of Interest

Liquid Biopsy

BOOK A MEETING

Disclaimer notice:

The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.

The opinions expresseda during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.

SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';